Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 19 Nov 20 424B4 Prospectus supplement with pricing info
- 19 Nov 20 EFFECT Notice of effectiveness
-
16 Nov 20 S-1/A IPO registration (amended)
- 30 Oct 20 S-1 IPO registration
OLMA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 18, 2020 (except for the effects of the reverse stock split discussed in Note 14, as to which the date is November 16, 2020) in Amendment No.1 to the Registration Statement (Form S-1 No. 333-249748) and related Prospectus of Olema Pharmaceuticals, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Redwood City, California
November 16, 2020